<p><b>A.</b> LH86 and <b>B.</b> Huh7 cells were treated with ABT-263 (0–20 µM) for up to 24 h. Apoptosis was measured through Hoechst staining to show apoptotic cells with condensed nuclei as described in ‘<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0021980#s2" target="_blank">materials and methods</a>’. (representative apoptotic cells were marked with white arrows in ABT-263 treatment panel). <b>C.</b> HCC cells were treated with increasing doses of ABT-263 as indicated for up to 24 h. Then cells were harvested and cell lysates were prepared and subjected to Western blotting. Caspase activation was assessed through detecting the cleaved bands of caspase 9 and caspase 3. β-actin protein levels were used as an equal...
<p>(A) Representative plots of flow cytometry analyses of HCT116 cells treated with <b>1d</b> or DMS...
<p>KTC-1 cells were left untreated as controls (<b>A</b>), or treated with 20 MBq/ml <sup>131</sup>I...
<p>The indicated transfectants were treated without and with 50 nM LBH589 plus 25 ng/ml TRAIL (L/T) ...
<p><b>A.</b> LH86 and <b>B.</b> Huh7 cells were untreated or treated with ABT-263(1 µM), YM-155(1 µM...
<p><b>A.</b> LH86 cells were treated with different doses of ABT-263 as indicated for 1 h. Cells wer...
<p><b>A.</b> Freshly prepared normal human hepatocytes were grown in 6-well plates. After two days l...
<p><b>A.</b> LH86 cells were treated as indicated and cell lysates were prepared for Western blottin...
<p>(a) H9 hESCs, FN2.1 hiPSCs, hESCs-derived NP and HF were treated with increasing concentrations o...
<p><b>A.</b> Huh7 cells were transiently transfected with synthesized random siRNA (control) or Bcl-...
<p>(A) The indicated cell lines were treated with MKT-077 (MKT) or 17-AAG alone or in combination at...
<p>(A) Hep G2, SMMC7721 and LO2 cells treated with ARG (0, 1.56, 12.5, 100 μM) for 24 h were double-...
<p>HepG2 cells were treated with 0.6 mM H<sub>2</sub>O<sub>2</sub> for 8 h. (A) The percentage of ap...
<p>MIN6 cells were mock-infected or infected with 1.0 MOI of HCV. (<b>A</b>) Confocal image of cells...
<p>Huh7 and Mahlavu cells were treated with 5, 25 and 50 μg/ml of HH-F3 for 48 hrs. The cells were s...
<p>(<b>A</b>) K562 cells were treated with 100 µM BSO and 10 µM HCH either alone or in combination f...
<p>(A) Representative plots of flow cytometry analyses of HCT116 cells treated with <b>1d</b> or DMS...
<p>KTC-1 cells were left untreated as controls (<b>A</b>), or treated with 20 MBq/ml <sup>131</sup>I...
<p>The indicated transfectants were treated without and with 50 nM LBH589 plus 25 ng/ml TRAIL (L/T) ...
<p><b>A.</b> LH86 and <b>B.</b> Huh7 cells were untreated or treated with ABT-263(1 µM), YM-155(1 µM...
<p><b>A.</b> LH86 cells were treated with different doses of ABT-263 as indicated for 1 h. Cells wer...
<p><b>A.</b> Freshly prepared normal human hepatocytes were grown in 6-well plates. After two days l...
<p><b>A.</b> LH86 cells were treated as indicated and cell lysates were prepared for Western blottin...
<p>(a) H9 hESCs, FN2.1 hiPSCs, hESCs-derived NP and HF were treated with increasing concentrations o...
<p><b>A.</b> Huh7 cells were transiently transfected with synthesized random siRNA (control) or Bcl-...
<p>(A) The indicated cell lines were treated with MKT-077 (MKT) or 17-AAG alone or in combination at...
<p>(A) Hep G2, SMMC7721 and LO2 cells treated with ARG (0, 1.56, 12.5, 100 μM) for 24 h were double-...
<p>HepG2 cells were treated with 0.6 mM H<sub>2</sub>O<sub>2</sub> for 8 h. (A) The percentage of ap...
<p>MIN6 cells were mock-infected or infected with 1.0 MOI of HCV. (<b>A</b>) Confocal image of cells...
<p>Huh7 and Mahlavu cells were treated with 5, 25 and 50 μg/ml of HH-F3 for 48 hrs. The cells were s...
<p>(<b>A</b>) K562 cells were treated with 100 µM BSO and 10 µM HCH either alone or in combination f...
<p>(A) Representative plots of flow cytometry analyses of HCT116 cells treated with <b>1d</b> or DMS...
<p>KTC-1 cells were left untreated as controls (<b>A</b>), or treated with 20 MBq/ml <sup>131</sup>I...
<p>The indicated transfectants were treated without and with 50 nM LBH589 plus 25 ng/ml TRAIL (L/T) ...